Lv7
4110 积分 2023-08-21 加入
Global liver disease burdens and research trends: Analysis from a Chinese perspective
2个月前
已完结
Liver cirrhosis
2个月前
已完结
Global epidemiology of cirrhosis — aetiology, trends and predictions
2个月前
已完结
Cell therapy for liver disorders: past, present and future
2个月前
已完结
High prevalence of steatotic liver disease and fibrosis in the general population: A large prospective study in China
3个月前
已完结
Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis
4个月前
已完结
肝癌肝切除围手术期管理中国专家共识(2021年版)
5个月前
已完结
肝细胞癌全程管理中国专家共识2023版
5个月前
已完结
Harnessing immunotherapy for hepatocellular carcinoma: Principles and emerging promises
5个月前
已完结
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
5个月前
已完结
皖公网安备34019202002308
